Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019

Background. Aplastic anemia is a failure of the process of formation and development of blood cells that causes a decrease or absence of hematopoietic precursor cells in the bone marrow. Although the prevalence of this disease is rare, aplastic anemia has the potential to cause death with risk facto...

Full description

Bibliographic Details
Main Authors: Amanda Rizki, Zelly Dia Rofinda, Gusti Revilla
Format: Article
Language:English
Published: Fakultas Kedokteran Universitas Andalas 2021-07-01
Series:Jurnal Ilmu Kesehatan Indonesia
Subjects:
Online Access:http://jikesi.fk.unand.ac.id/index.php/jikesi/article/view/274
_version_ 1797817103754985472
author Amanda Rizki
Zelly Dia Rofinda
Gusti Revilla
author_facet Amanda Rizki
Zelly Dia Rofinda
Gusti Revilla
author_sort Amanda Rizki
collection DOAJ
description Background. Aplastic anemia is a failure of the process of formation and development of blood cells that causes a decrease or absence of hematopoietic precursor cells in the bone marrow. Although the prevalence of this disease is rare, aplastic anemia has the potential to cause death with risk factors that are easily found in everyday life and are rarely realized. Objective. To determine the profile of patients with aplastic anemia at General Hospital Dr M Djamil Padang. Methods. This is a descriptive retrospective study. The population of this study are all patients diagnosed with aplastic anemia by clinicians in the Medical Record Installation of Dr. M. Djamil Hospital, Padang, between 1 January 2018 - 31 December 2019.. Results The results showed that 21.57% patients with aplastic anemia were at the age of 56-65 years and the incidence was higher in women than men. The highest risk factor was exposure to chemical and insecticides (18.62%), but 54.9% of the data did not include risk factors. 31.37% work as students. 67.65% suffered from mild aplastic anemia, 60.78% were on immunosuppressive therapy, and 65.69% had partial remission outcomes. Conclusion. The majority of patients with aplastic anemia based on age are 56-65 years and based on gender, the incidence is higher in women. The most common risk factors were exposure to chemical and insecticides. . The most common level of severity is non-severe aplastic anemia. The most common type of therapy is immunosuppressive therapy. The most common outcome is partial remission.
first_indexed 2024-03-13T08:48:15Z
format Article
id doaj.art-91437009d72f4ab4a964f212dc380bc2
institution Directory Open Access Journal
issn 2722-4848
language English
last_indexed 2024-03-13T08:48:15Z
publishDate 2021-07-01
publisher Fakultas Kedokteran Universitas Andalas
record_format Article
series Jurnal Ilmu Kesehatan Indonesia
spelling doaj.art-91437009d72f4ab4a964f212dc380bc22023-05-29T22:19:17ZengFakultas Kedokteran Universitas AndalasJurnal Ilmu Kesehatan Indonesia2722-48482021-07-012116416910.25077/jikesi.v2i1.274274Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019Amanda Rizki0Zelly Dia Rofinda1Gusti Revilla2Fakultas Kedokteran Universitas AndalasBagian Patologi Klinik Fakultas Kedokteran Universitas AndalasBagian Anatomi Fakultas Kedokteran Universitas AndalasBackground. Aplastic anemia is a failure of the process of formation and development of blood cells that causes a decrease or absence of hematopoietic precursor cells in the bone marrow. Although the prevalence of this disease is rare, aplastic anemia has the potential to cause death with risk factors that are easily found in everyday life and are rarely realized. Objective. To determine the profile of patients with aplastic anemia at General Hospital Dr M Djamil Padang. Methods. This is a descriptive retrospective study. The population of this study are all patients diagnosed with aplastic anemia by clinicians in the Medical Record Installation of Dr. M. Djamil Hospital, Padang, between 1 January 2018 - 31 December 2019.. Results The results showed that 21.57% patients with aplastic anemia were at the age of 56-65 years and the incidence was higher in women than men. The highest risk factor was exposure to chemical and insecticides (18.62%), but 54.9% of the data did not include risk factors. 31.37% work as students. 67.65% suffered from mild aplastic anemia, 60.78% were on immunosuppressive therapy, and 65.69% had partial remission outcomes. Conclusion. The majority of patients with aplastic anemia based on age are 56-65 years and based on gender, the incidence is higher in women. The most common risk factors were exposure to chemical and insecticides. . The most common level of severity is non-severe aplastic anemia. The most common type of therapy is immunosuppressive therapy. The most common outcome is partial remission.http://jikesi.fk.unand.ac.id/index.php/jikesi/article/view/274aplastic anemiapatient’s profilerisk factor
spellingShingle Amanda Rizki
Zelly Dia Rofinda
Gusti Revilla
Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019
Jurnal Ilmu Kesehatan Indonesia
aplastic anemia
patient’s profile
risk factor
title Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019
title_full Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019
title_fullStr Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019
title_full_unstemmed Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019
title_short Profil Penderita Anemia Aplastik di RSUP Dr. M. Djamil Padang Tahun 2018-2019
title_sort profil penderita anemia aplastik di rsup dr m djamil padang tahun 2018 2019
topic aplastic anemia
patient’s profile
risk factor
url http://jikesi.fk.unand.ac.id/index.php/jikesi/article/view/274
work_keys_str_mv AT amandarizki profilpenderitaanemiaaplastikdirsupdrmdjamilpadangtahun20182019
AT zellydiarofinda profilpenderitaanemiaaplastikdirsupdrmdjamilpadangtahun20182019
AT gustirevilla profilpenderitaanemiaaplastikdirsupdrmdjamilpadangtahun20182019